Viral Vector News and Research

RSS
Viral Vector is a type of virus used in cancer therapy. The virus is changed in the laboratory and cannot cause disease. Viral vectors may produce tumor antigens (proteins found on a tumor cell) to stimulate an antitumor immune response in the body. Viral vectors may also be used to carry genes that can change cancer cells back to normal cells.
SARS-CoV-2 oral vaccine booster shows promise in animal tests

SARS-CoV-2 oral vaccine booster shows promise in animal tests

Study reports on the immunogenicity of single-shot COVID-19 vaccine against SARS-CoV-2 variants

Study reports on the immunogenicity of single-shot COVID-19 vaccine against SARS-CoV-2 variants

Researchers review environmental risk assessments for recombinant COVID-19 viral vector vaccines

Researchers review environmental risk assessments for recombinant COVID-19 viral vector vaccines

Researchers develop proof-of-concept treatment for blood disorders

Researchers develop proof-of-concept treatment for blood disorders

Study shows CoronaVac to have high seroconversion rate after 40 days

Study shows CoronaVac to have high seroconversion rate after 40 days

Researchers identify aluminum hydroxide/TLR9 agonist as potential adjuvant to improve RBD-based COVID-19 vaccine efficacy

Researchers identify aluminum hydroxide/TLR9 agonist as potential adjuvant to improve RBD-based COVID-19 vaccine efficacy

Sequentia collaborated with Nextbiomics to obtain a novel immunization model against COVID-19

Sequentia collaborated with Nextbiomics to obtain a novel immunization model against COVID-19

An intranasal COVID-19 vaccine elicits long-lasting immunity against SARS-CoV-2 variants in vivo

An intranasal COVID-19 vaccine elicits long-lasting immunity against SARS-CoV-2 variants in vivo

Experimental gene therapy successfully treats children born without an immune system

Experimental gene therapy successfully treats children born without an immune system

The "key" to vaccine development depends on virus’ binding to human cells

The "key" to vaccine development depends on virus’ binding to human cells

Researchers use gene therapy to prevent learning, memory loss in Alzheimer's mouse model

Researchers use gene therapy to prevent learning, memory loss in Alzheimer's mouse model

Albumedix extends research collaboration with Cobra Biologics to optimize viral vector manufacturing

Albumedix extends research collaboration with Cobra Biologics to optimize viral vector manufacturing

Genethon announces dosing of first patient at pediatric clinical trial platform for neuromuscular diseases

Genethon announces dosing of first patient at pediatric clinical trial platform for neuromuscular diseases

Research says benefits of continuing immunization of front-line workers in BC with AstraZeneca vaccine far outweigh risks

Research says benefits of continuing immunization of front-line workers in BC with AstraZeneca vaccine far outweigh risks

Researchers evaluate new drug for spinal muscular atrophy in a broader spectrum of patients

Researchers evaluate new drug for spinal muscular atrophy in a broader spectrum of patients

Fight for Sight funds research to explore gene editing as treatment for inherited retinal diseases

Fight for Sight funds research to explore gene editing as treatment for inherited retinal diseases

mRNA COVID-19 vaccines are highly effective among front liners, CDC study shows

mRNA COVID-19 vaccines are highly effective among front liners, CDC study shows

Single Sputnik V vaccine dose elicits robust immune response in previously infected individuals

Single Sputnik V vaccine dose elicits robust immune response in previously infected individuals

Dual-antigen COVID-19 vaccine elicits humoral and cellular immune responses in mice

Dual-antigen COVID-19 vaccine elicits humoral and cellular immune responses in mice

AstraZeneca's COVID-19 vaccine protects against symptomatic disease

AstraZeneca's COVID-19 vaccine protects against symptomatic disease